By: Elizabeth Landry
Encompassing treatment centers at both St. Peter’s Hospital in Albany and Samaritan Hospital in Troy, St. Peter’s Health Partners (SPHP) Cancer Care has been providing advanced cancer care to patients in the greater Capital Region for more than 40 years. From outpatient chemotherapy and immunotherapy to surgical consultations and second opinions, the cancer team at SPHP strives to deliver patient-centered care during a time when it’s needed the most, directly within patients’ own communities.
“First and foremost, we can’t take a diagnosis of
cancer away from a patient. But what we can do is make sure that the patient and their family and caregivers are not going through the journey alone,” said Nicholas Montalto, MD, Chief Medical Officer for SPHP Acute Care. “What we try to do is provide compassionate, evidence based care from the moment of diagnosis through treatment and recovery,” which includes a dedicated support structure to help patients and their families process their diagnosis, understand treatments, and even receive assistance with out-ofpocket expenses like transportation and housing costs.
To accomplish this goal, SPHP offers a multi disciplinary, team approach involving medical oncologists, radiation oncologists, surgeons, nurses, pharmacists, social workers, rehabilitation specialists and palliative care specialists, Dr. Montalto explained.
Working together, these care providers offer treatments for a broad range of cancers and blood diseases, including breast cancer, colorectal cancer, gastrointestinal cancer, gynecologic cancer, head and neck cancer, lung cancer, and urologic cancer. Early detection and preventive measures are key – SPHP works with primary care physicians to
provide free cancer screenings, as well.
“The cancer care programs at St. Peter’s have been running for more than 40 years and are designed to offer a variety of services. In addition to the medical oncology and hematology program, we have a fantastic program of surgeons providing thoracic surgery, breast surgery, genitourinary surgery, and hepatobiliary surgery,” said John Weinhold, MD, acting Chief of Hematology Oncology Services at SPHP.
Enhanced Access to Nationally Ranked Care
Recent advancements in cancer care at SPHP demonstrate the organization’s commitment to providing patients with cutting-edge treatments and advanced care directly within their communities.
Last year, St. Peter’s Health Partners Medical Oncology announced that it is now a member of the Roswell Park Care Network, affording patients access to a nationally designated comprehensive cancer center.
This partnership with Roswell Park Comprehensive Cancer Center has brought access to front-line cancer expertise, advanced diagnostics, and innovative treatment options for patients across the Capital Region, as Dr. Montalto explained.
“Our partnership with Roswell Park has been one of the most exciting things, I think, to happen to St. Peter’s Health Partners. This affiliation with a comprehensive, nationally ranked, premier cancer center gives us access to everything a comprehensive cancer center offers. That can be access to clinical trials, to even more cutting-edge technology, and access to all the physician talent that exists at such a renowned cancer center,” Dr. Montalto said.
Through this connection to Roswell Park, SPHP has gained access to educational programs, medical grand rounds, and surgical grand rounds, as well, Dr. Weinhold explained. Clinical trials and research programs are essential for investigating the newest and best cancer treatments, and through the Roswell Park Care Network, providers and patients at SPHP can become involved in clinical trials as well as genomic and genetic testing, multidisciplinary case reviews, and advanced clinical pathways for more personalized cancer treatments. Along with a switch from emphasis on chemotherapy to more targeted therapies and immunotherapies based on patients’ personal genetic and molecular abnormalities, “we now have many treatments which are much easier to administer at home,” said Dr. Weinhold.
Many providers just coming out of training programs are increasingly concentrating on cancer sub-specialties, Dr. Weinhold also explained. The partnership with Roswell Park has increased SPHP’s access to networks of providers who are attuned to a wide range of specific cancers.
“With the connection with Roswell, we can speak with people who see a particular range of cancers, so for example, we can talk with someone who treats sarcomas, which are uncommon cancers. We can talk with someone who treats very unusual blood diseases. We
can take advantage of this connection and provide more coordinated care for patients to be seen by sub-specialists at Roswell. I think that offers a step up in care,” said Dr. Weinhold.
Utilizing Precision Robotics for Earlier Cancer Detection
Along with the exciting partnership with Roswell Park, SPHP has also recently obtained cutting edge technology that has allowed certain kinds of cancer to be detected at earlier stages. Pulmonologists and surgeons at SPHP can now use the ION Robotic System from Intuitive Surgical: a state-of-the-art, roboticassisted platform that provides minimally invasive biopsies of small, hard-to-reach lung nodules without an incision or needle through the chest wall. The first case using the ION robot was performed in a special endoscopy suite at Samaritan Hospital on June 12.

“ION bronchoscopy enables computer and robotic-assisted, highly accurate biopsies to be performed through the airway while the patient is sound asleep and comfortable. It allows us to place small coils that glow in the dark for about two weeks, facilitating identification of half-inch nodules in the operating room with infrared light. This process allows much earlier diagnosis and minimally invasive treatment using the da Vinci robot. Most of our patients who require lung surgery can now go home one day after surgery,” said Tracey Weigel, MD, a thoracic surgeon who recently joined Albany Thoracic & Esophageal Surgery. She utilizes the ION robot along with Joseph Seguel, MD, a pulmonologist with Pulmonary & Critical Care Services.
Dr. Seguel emphasized the impact the ION robot has made by allowing for faster, more accurate diagnosis, which is critical because lung cancer remains the leading cause of death in the U.S. and delay in diagnosis leads to a documented upstage in the disease. He also explained that procedures using the ION robot are much safer than previously used methods.
“Traditional methods of diagnosis include regular bronchoscopy and navigational bronchoscopy, which rely on creating a ‘breadcrumb’ trail to the abnormal CT finding – typically a nodule,” said Dr. Seguel. “ION offers a more stable option to get biopsies in a much safer way,” with CT-guided biopsy carrying an approximately 20% risk of lung injury, compared to the ION robot’s 5% risk of injury. Additionally, multiple locations can be sampled in one procedure, and additional testing to rule infections can be performed at the same time.
The ION robot also represents a strong partnership between the thoracic surgery and pulmonology teams at SPHP, as biopsies by the pulmonologists result in peripheral nodules being marked and ready for minimally invasive surgery within two weeks.
“Planning for procedures while evaluating airways and targets is a new collaborative effort to help deliver the best care to patients,” said Dr. Seguel.
Targeted Treatment with Decreased Side Effects
Another important advancement in cancer care at SPHP involves technology that’s not necessarily new, but that is now being used alongside enhanced imaging technology to provide direct benefits to a segment of patients diagnosed with prostate cancer. St. Peter’s Hospital and Capital Region Urology have begun utilizing High-Intensity Focused Ultrasound (HIFU) technology to provide minimally invasive prostate cancer treatments. While HIFU has existed for over 20 years, the technology, which uses targeted ultrasound waves to destroy cancer cells without incisions or radiation, is now being paired with more precise imaging scans to provide significant benefits for patients.
“HIFU has been used in the U.S., but its success has been variable,” said Brian Murray, MD, Chief of Urology at St. Peter’s Hospital. “There’s a new technology called PSMA PET scans, which are incredibly good at finding localized prostate cancer. We don’t want to treat someone with HIFU, or focal therapy, if there’s disease in many parts of the prostate, or if it’s already spread outside the prostate. The system we have now lets you really steer the focused ultrasound very accurately in the prostate to carve out this limited area where you know the cancer is. This series of advancements in technology has allowed this to become a mainstay treatment for people who have localized prostate cancer,” which is about 35% of men who have prostate cancer and need treatment.
The procedure using HIFU takes about two hours and is done under anesthesia in the hospital, Dr. Murray explained. Afterward, patients tend to experience very little pain or voiding symptoms. HIFU is approved to treat benign disease of the prostate as well as prostate cancer. Importantly, the treatment preserves healthy surrounding tissue and typically doesn’t leave patients with life-altering side effects like urinary incontinence and erectile dysfunction, which are more commonly experienced when the entire prostate is removed or radiated, Dr. Murray explained.
“By treating just part of the prostate, we avoid coming in contact with the nerves that lay just outside of the prostate, or which run through the prostate,” Dr. Murray said. “This means the treatment isn’t leaving patients with incontinence or erectile dysfunction, which are two of the main concerns men have when they decide to treat their prostate cancer.”
Since last fall, there have been more than 25 HIFU procedures performed at SPHP, and demand for this minimally invasive surgery is increasing as awareness of its availability grows. “With the data coming in now about outcomes, HIFU needs to be part of the treatment discussion. It won’t be suitable for every patient, but for the men who are candidates for this prostate-sparing surgery, the outcomes are huge regarding quality of life,” said Dr. Murray. “Being able to offer patients something that can treat the cancer and reduce side effects is really opening doors for a lot of people.”
Continued Investments in Patient-Centered Cancer Care
While HIFU technology has trickled down from other cancer applications to the treatment of prostate cancer, SPHP is continuing to invest in ultrasound technology for expanded urological treatments, as well. Whether it’s regarding robotics, targeted ultrasound treatment, or partnering with leading nationwide cancer care experts, investing in new technologies that benefit patient outcomes appears to be a common theme at SPHP.
“Dr. Hanks [President and CEO of SPHP] has been a strong advocate of robotics for SPHP. He has always supported the implementation of new technologies to help deliver care with cutting edge technology,” said Dr. Seguel.
Of course, all advancements in care come down to how patients are directly benefited when they come to SPHP and receive care in their own communities.
“People like coming to our cancer centers because they’re comfortable, peaceful places to get treatment,” Dr. Weinhold said.
“It’s all about access,” added Dr. Montalto. “Allowing patients to stay in the community where they live and feel their strongest support is so important.”

Interesting conversation with a patient last week about their mounting health care debt. Higher premiums, higher deductibles, higher co-pays, more out of formulary uncovered meds all adding up to $45,000 in annual out of pocket costs.

Disputes in the health care sector are inevitable. Whether they arise between physicians in a group practice, between an ambulatory surgical center and its member surgeons, or between a hospital system and an affiliated provider, conflicts over governance, compensation, non compete agreements, or operational decisions can quickly consume the time, energy, and resources of all involved. Litigation has long been the default mechanism for resolving such conflicts, but it is rarely the best one. Mediatio —particularly when guided by an experienced health care attorney serving as mediator—offers a faster, more cost-effective, and more relationship-preserving alternative that deserves serious consideration.
Albany Med Health System is the largest and only academic health system in northeastern New York and western New England. It includes Albany Medical Center, Albany Medical College, Columbia Memorial Health, Glens Falls Hospital, Saratoga Hospital, and Visiting Nurses.
“Our first focus is on what’s not going to change,” he said of the First Choice 2030 initiative. “Right now, we have four hospitals, a college, an outpatient practice, visiting nurses. We’ve got almost 1,000 doctors that operate across 100 different points of care. What’s not going to change is our passion for making sure we are operating as effectively as we can. “At the end of the day, if you’re focused on those things and doing them in an efficient way with increasing movement from volume to value, you’ll be a winner, and you’ll be first choice that’s what we’re working toward.”
level right down to all the different places we support that provide care. My job is to help staff do more of what’s working and unblock the things that aren’t so they can do what they invested an incredible amount of time to do.”
Even before construction is complete, Albany Medical Center has implemented changes to care, including decreased wait times. “Not only are we growing to meet our mission—we continuously strive to improve upon how we deliver our mission,” said Jason Mouzakes, MD, president and CEO of Albany Medical Center Hospital. “Rethinking the blueprint for our emergency department and how patients move from arrival through discharge or hospital admission will allow us to transform the patient
Established in 1986, the Bernard & Millie Duker Children’s Hospital contains 125 beds devoted exclusively to the medical needs of patients under 18 years of age. It is the referral center for all seriously ill and injured children from 25 counties across upstate New York and western New England.
For as long as he can remember, Dr. Martin “Marty” Stallone has held two unwavering truths: he wanted to be a physician, and he wanted to serve his country. Both were anchored by clear purpose.
how care is delivered and where it often breaks down. He saw firsthand the pressures facing providers, the operational realities behind clinical decisions, and the importance of aligning strategy with real-world practice.
Latham, NY, and founded more than 40 years ago by local physicians committed to doing what’s right for the community. Already familiar with – and impressed by – the organization’s long-standing focus on keeping patients at the center of care, Dr. Stallone saw an opportunity to help advance that mission even further.
At the core of his vision is partnership. Drawing on his experience as both a physician and a former health system CEO, Stallone sees collaboration as the most effective path forward in an increasingly complex healthcare environment. He designs practical, sustainable, and impactful programs by grounding his strategy in the real challenges facing the healthcare system, including rising costs.
independent multi specialty medical practice. In 2022, CDPHP and Community Care Physicians took a bold step to transform care for thousands of Capital Region residents, creating a more seamless, coordinated experience for both patients and their providers.

“The team’s surgical expertise enables them to not only perform traditional CABG (coronary artery bypass graft) procedures, but also virtually any complex cardiac condition,” explained Dr. Montalto. “Our surgeons specialize in repair and replacement of mitral and aortic valves as well as surgery for aortic aneurysms. This expertise is why St. Peter’s cardiac surgery is consistently ranked among the highest quality programs in New York state.”
“We are developing a specialized program to treat patients who come in for heart surgery for other conditions like coronary artery disease or heart valve issues and have heart failure,” he said. “We’ll have the technology to care for patients with heart failure at the same time when we’re handling coronary vascularization or heart valve replacement.”
provides expert yet convenient surgical care for patients is through concomitant procedures, as described by Dr. Helmer, a surgeon with more than 20 years of experience and expertise in heart bypass surgery, heart valve surgery, and other conditions. Some of the heart procedures and surgeries at St. Peter’s can be performed in the same surgery – such as the Maze procedure for ablation of atrial fibrillation – bringing another level of convenience for patients.
“The business of keeping that hemoglobin up and avoiding a transfusion involves several people. Once the heart starts to beat again, and we come off the bypass, the blood left in the machine is given back to the patient. It’s a meticulous technique and an expeditious operation,” Dr. Hasan said, adding that patients can also take iron and folic acid supplements as well as medications to stimulate bone marrow ahead of the procedure to help reduce dilution of the blood. These options are beneficial to all patients, he said, but especially those who may have personal or religious reasons to avoid blood transfusions.
Center successfully completed Bassett Healthcare Network’s first GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE) procedure in October 2025.
implanted to treat the aneurysm. After the patient is under anesthesia, it is inserted into the body through a small incision and, through the use of needle punctures and imaging, is guided into place.
Private equity (PE) investment in healthcare has grown quickly, reshaping how medical practices run day to day. For physicians and practice owners, selling to a PE firm is a complex decision. It can open doors for growth and support, but it also brings challenges. —offering strategic advantages and potential pitfalls. In New York State, strict regulatory constraints add another layer of complexity that need to be understood before moving forward.